Freeman Kevin Lee
- SEC CIK
- 0001945797
No open-market purchases or sales filed in the past year.
Current role at each company
- HCAT Health Catalyst, Inc.Chief Commercial Officeras of Dec 3, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Freeman Kevin Lee as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2024 (view filing) | Dec 2 | 1 day | Freeman Kevin LeeChief Commercial Officer | SSale | −7.50K | $8.94 | −$67.0K | −3.1%236.9K after | |
| Sep 5, 2024 (view filing) | Sep 3 | 2 days | Freeman Kevin LeeChief Commercial Officer | SSale | −7.50K | $7.22 | −$54.1K | −2.8%255.9K after | |
| Jun 12, 2024 (view filing) | Jun 11 | 1 day | Freeman Kevin LeeChief Commercial Officer | SSale | −7.50K | $6.53 | −$49.0K | −2.7%266.2K after | 10b5-1 |